Publication: Economic evaluations of hepatitis A vaccination in middle-income countries
Issued Date
2013-12-01
Resource Type
ISSN
17448395
14760584
14760584
Other identifier(s)
2-s2.0-84887651323
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Expert Review of Vaccines. Vol.12, No.12 (2013), 1479-1494
Suggested Citation
Auliya A. Suwantika, Selen Yegenoglu, Arthorn Riewpaiboon, Hong Anh T. Tu, Maarten J. Postma Economic evaluations of hepatitis A vaccination in middle-income countries. Expert Review of Vaccines. Vol.12, No.12 (2013), 1479-1494. doi:10.1586/14760584.2013.851008 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/31156
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Economic evaluations of hepatitis A vaccination in middle-income countries
Abstract
Economic evaluations of hepatitis A vaccination are important to assist national and international policy makers in different jurisdictions on making effective decisions. Up to now, a comprehensive review of the potential health and economic benefits on hepatitis A vaccination in middle-income countries (MICs) has not been performed yet. In this study, we reviewed the literature on the cost-effectiveness of hepatitis A vaccination in MICs. Most of the studies confirmed that hepatitis A vaccination was cost effective or even cost saving under certain conditions. We found that vaccine price, medical costs, incidence and discount rate were the most influential parameters on the sensitivity analyses. Vaccine price has been shown as a barrier for MICs in implementing universal vaccination of hepatitis A. Given their relatively limited financial resources, implementation of single-dose vaccination could be considered. Despite our findings, we argue that further economic evaluations in MICs are still required in the near future. © Informa UK, Ltd.